EUTM file information

018645931

AMPCASUS


January 30, 2022

Trademark Summary

The trademark application AMPCASUS was filed by Celgene Corporation, a U.S. corporation (the "Applicant"). The application was published for oppositions on March 10, 2022, and it was registered by office on June 17, 2022 without any oppositions.

The application was filed in English (French was selected as the second language).


Goods And Services

  • The mark was filed in class 5 with Pharmaceutical preparations for human use and biological preparations for medical purposes..
Trademarkers